Mimedx (MDXG) Accumulated Expenses (2011 - 2026)

Mimedx has disclosed Accumulated Expenses across 16 years of filings, most recently posting $14.5 million for Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $14.5 million, down 22.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.5 million (down 22.51% YoY), and the FY2025 annual result was $31.1 million, up 244.71% from the prior year.
• Accumulated Expenses came in at $14.5 million for Q1 2026 at Mimedx, down from $31.1 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $31.1 million in Q4 2025 to a low of $8.4 million in Q3 2024.
• The 5-year median for Accumulated Expenses is $17.9 million (2024), against an average of $17.3 million.
• Across the five-year window, Accumulated Expenses tumbled 68.01% in 2022 and soared 244.71% in 2025, its largest moves.
• Mimedx's Accumulated Expenses stood at $20.9 million in 2022, then gained by 7.18% to $22.4 million in 2023, then plunged by 59.68% to $9.0 million in 2024, then jumped by 244.71% to $31.1 million in 2025, then plunged by 53.25% to $14.5 million in 2026.
• The last three Accumulated Expenses figures came in at $14.5 million (Q1 2026), $31.1 million (Q4 2025), and $27.6 million (Q3 2025), per Business Quant data.